ReviewJournal of cardiothoracic surgery2016
The clinical features, diagnosis and management of recurrent thymoma.
Review in Journal of cardiothoracic surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04577495 (Correlation of CT Scan Parameters With Histology, Stage and Prognosis in Surgically-treated Thymomas), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Correlation of CT Scan Parameters With Histology, Stage and Prognosis in Surgically-treated Thymomas
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.
- Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis.Cancer control : journal of the Moffitt Cancer CenterPooled it
- Myasthenia Gravis and Thymoma.Muscle & nerve · 2026Review
- Matrine suppresses thymoma stemness and apoptosis via YTH N6-methyladenosine RNA binding protein 1 and Wnt/β-catenin signaling.3 Biotech · 2026Article
- Recurrence and primary TETs: is it the same disease?-a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Advanced Masaoka-Koga stage as an independent predictor of thymoma recurrence after complete resection: myasthenia gravis was not an independent factor.Gland surgery · 2025Article
- Oncologic outcomes and predictors of recurrence following minimally invasive and open surgery for thymoma.Journal of thoracic disease · 2025Article
- Robot-Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort Study.Journal of surgical oncology · 2025Article
- Article
- [Clinical characteristics and prognosis of 21 patients with thymoma-associated pure red cell aplasia].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2023Article
- Thymoma: An Overview.Diagnostics (Basel, Switzerland) · 2023Review
- Anterior mediastinal tumor surgery applying single-port thoracoscopy using the subxiphoid approach.Turk gogus kalp damar cerrahisi dergisi · 2023Article
- MC-ViT: Multi-path cross-scale vision transformer for thymoma histopathology whole slide image typing.Frontiers in oncology · 2022Article
- Pure White Cell Aplasia and Immune Thrombocytopenia after Thymoma Resection: A Case Report and Review of the Literature.Case reports in hematology · 2022Article
- Diagnostic and prognostic value of FDG PET-CT in patients with suspected recurrent thymic epithelial tumors.Scientific reports · 2021Article
- Article
- Surgical management of thymic epithelial tumors.Surgery today · 2021Review
- Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.Thoracic cancer · 2021Article
- Correlation of Computed Tomography Parameters with Histology, Stage and Prognosis in Surgically Treated Thymomas.Medicina (Kaunas, Lithuania) · 2020Article
- Surgical treatment of single and multiple thymoma recurrences.General thoracic and cardiovascular surgery · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymoma is a disease with malignant potential, which has a recurrence rate after complete resection ranging from 5 to 50 %. Multiple studies on the risk factors, treatment or prognosis have been reported. Many of them are controversial, however. In this review, we summarized some accepted risk factors, means of diagnosis and different treatments of recurrent thymoma. The risk factors of recurrent thymoma haven't been well-studied, and its management remains controversial. We reviewed the literatures and found some key points which should be noticed during the surgery of initial thymoma. Although reoperation should be taken into account preferentially, multimodal treatments are also available. The prognosis are also been discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.